Ritlecitinib for Cicatricial Alopecia

Clinical trial NCT05549934 · COMPLETED

Trial details

NCT number: NCT05549934
Sponsor: Emma Guttman
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cicatricial Alopecia

Start date: 2022-12-15
Primary completion: 2025-03-20
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.